Search Results - "VANBROCKLIN, H. F"

Refine Results
  1. 1

    Safety and tolerability of putaminal AADC gene therapy for Parkinson disease by CHRISTINE, C. W, STARR, P. A, LARSON, P. S, EBERLING, J. L, JAGUST, W. J, HAWKINS, R. A, VANBROCKLIN, H. F, WRIGHT, J. F, BANKIEWICZ, K. S, AMINOFF, M. J

    Published in Neurology (17-11-2009)
    “…In Parkinson disease (PD), the benefit of levodopa therapy becomes less marked over time, perhaps because degeneration of nigrostrial neurons causes…”
    Get full text
    Journal Article
  2. 2

    [(11)C]Ascorbic and [(11)C]dehydroascorbic acid, an endogenous redox pair for sensing reactive oxygen species using positron emission tomography by Carroll, V N, Truillet, C, Shen, B, Flavell, R R, Shao, X, Evans, M J, VanBrocklin, H F, Scott, P J H, Chin, F T, Wilson, D M

    “…Here we report the radiosynthesis of an endogenous redox pair, [(11)C]ascorbic acid ([(11)C]VitC) and [(11)C]dehydroascorbic acid ([(11)C]DHA), the reduced and…”
    Get more information
    Journal Article
  3. 3

    PET studies of functional compensation in a primate model of Parkinsonʼs disease by Eberling, J L, Bankiewicz, K S, Jordan, S, VanBrocklin, H F, Jagust, W J

    Published in Neuroreport (18-08-1997)
    “…MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is a neurotoxin that produces degeneration of nigrostriatal dopaminergic neurons and a chronic parkinsonian…”
    Get full text
    Journal Article
  4. 4

    Dicarboxylic acids as pH sensors for hyperpolarized 13 C magnetic resonance spectroscopic imaging by Korenchan, D E, Taglang, C, von Morze, C, Blecha, J E, Gordon, J W, Sriram, R, Larson, P E Z, Vigneron, D B, VanBrocklin, H F, Kurhanewicz, J, Wilson, D M, Flavell, R R

    Published in Analyst (London) (02-05-2017)
    “…Imaging tumoral pH may help to characterize aggressiveness, metastasis, and therapeutic response. We report the development of hyperpolarized [2- C,D…”
    Get more information
    Journal Article
  5. 5

    A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes by Eberling, Jamie L., Jagust, William J., Taylor, Scott, Bringas, John, Pivirotto, Phillip, VanBrocklin, Henry F., Bankiewicz, Krys S.

    Published in Brain research (14-09-1998)
    “…Positron emission tomography (PET) and the dopamine (DA) metabolism tracer, [ 18 F] 6-fluoro- l- m-tyrosine (FMT) were used to evaluate the relationship…”
    Get full text
    Journal Article
  6. 6

    Iodine-123-5-Iodo-6-Nitroquipazine: SPECT Radiotracer to Image the Serotonin Transporter by Jagust, William J, Eberling, Jamie L, Biegon, Anat, Taylor, Scott E, VanBrocklin, Henry F, Jordan, Shaun, Hanrahan, Stephen M, Roberts, Jeffrey A, Brennan, Kathleen M, Mathis, Chester A

    Published in The Journal of nuclear medicine (1978) (01-07-1996)
    “…Because serotonergic function has been implicated in the pathophysiology of a number of diseases of the nervous system, efforts to image this system in vivo…”
    Get full text
    Journal Article
  7. 7

    20-[18F]Fluoromibolerone, a Positron-Emitting Radiotracer for Androgen Receptors: Synthesis and Tissue Distribution Studies by Liu, Aijun, Katzenellenbogen, John A, VanBrocklin, Henry F, Mathias, Carla J, Welch, Michael J

    Published in The Journal of nuclear medicine (1978) (01-01-1991)
    “…To develop an androgen receptor-based, positron-emitting imaging agent for prostate tumors, we have prepared 20-fluoromibolerone (F-Mib) and evaluated its…”
    Get full text
    Journal Article
  8. 8

    Fluorine-18 labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors by Kochanny, Monica J, VanBrocklin, Henry F, Kym, Philip R, Carlson, Kathryn E, O'Neil, James P, Bonasera, Thomas A, Welch, Michael J, Katzenellenbogen, John A

    Published in Journal of medicinal chemistry (30-04-1993)
    “…We have studied two new fluorine-substituted progestins as potential imaging agents for progesterone-receptor-positive human breast tumors. The steroids are 16…”
    Get full text
    Journal Article
  9. 9

    An in vivo microdialysis study of striatal 6-[18F]fluoro-L-m-tyrosine metabolism by JORDAN, S, BANKIEWICZ, K. S, EBERLING, J. L, VANBROCKLIN, H. F, O'NEIL, J. P, JAGUST, W. J

    Published in Neurochemical research (01-04-1998)
    “…In vivo brain microdialysis was used to monitor 6-[18F]fluoro-L-m-tyrosine (FMT) uptake and metabolism in the striatum of conscious freely moving rats for 3…”
    Get full text
    Journal Article
  10. 10

    Anilinodialkoxyquinazolines:  Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Potential Tumor Imaging Probes by VanBrocklin, Henry F, Lim, John K, Coffing, Stephanie L, Hom, Darren L, Negash, Kitaw, Ono, Michele Y, Gilmore, Jennifer L, Bryant, Ianthe, Riese, David J

    Published in Journal of medicinal chemistry (17-11-2005)
    “…The epidermal growth factor receptor (EGFR), a long-standing drug development target, is also a desirable target for imaging. Sixteen dialkoxyquinazoline…”
    Get full text
    Journal Article
  11. 11
  12. 12

    PET studies of cerebral glucose metabolism in conscious rhesus macaques by Eberling, Jamie L., Roberts, Jeffrey A., De Manincor, Darlene J., Brennan, Kathleen M., Hanrahan, Stephen M., Vanbrocklin, Henry F., Roos, Mark S., Jagust, William J.

    Published in Neurobiology of aging (01-09-1995)
    “…A growing body of evidence suggests that rhesus macaques may be a good model of human brain aging. We used positron emission tomography (PET) and…”
    Get full text
    Journal Article
  13. 13

    Synthesis and Tissue Biodistribution of [.omega.-11C]Palmitic Acid. A Novel Pet Imaging Agent for Cardiac Fatty acid Metabolism by Buckman, Brad O, VanBrocklin, Henry F, Dence, Carmen S, Bergmann, Steven R, Welch, Michael J, Katzenellenbogen, John A

    Published in Journal of medicinal chemistry (01-07-1994)
    “…In order to diagnose patients with medium-chain acyl-CoA dehydrogenase deficiency with a noninvasive diagnostic technique such as positron emission tomography,…”
    Get full text
    Journal Article
  14. 14

    No effect of age and estrogen on aromatic L- amino acid decarboxylase activity in rhesus monkey brain by Eberling, Jamie L., Roberts, Jeffrey A., Taylor, Scott E., VanBrocklin, Henry F., O’Neil, James P., Nordahl, Thomas E.

    Published in Neurobiology of aging (01-05-2002)
    “…A variety of studies have shown an effect of estrogen on dopamine function and suggest that estrogen may modulate central dopaminergic activity. Positron…”
    Get full text
    Journal Article
  15. 15

    16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors by VanBrocklin, H F, Carlson, K E, Katzenellenbogen, J A, Welch, M J

    Published in Journal of medicinal chemistry (28-05-1993)
    “…In order to understand the structural features that might lead to an estrogen receptor (ER) based breast tumor imaging agent with improved uptake…”
    Get full text
    Journal Article
  16. 16

    The synthesis of 7 alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents by VanBrocklin, H F, Liu, A, Welch, M J, O'Neil, J P, Katzenellenbogen, J A

    Published in Steroids (01-01-1994)
    “…The 7 alpha-methyl substituent is reported to increase the binding affinity of estradiol for the estrogen receptor (ER). In order to evaluate whether this…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Development of an optimized activatable MMP-14 targeted SPECT imaging probe by Watkins, Gregory A., Jones, Ella Fung, Scott Shell, M., VanBrocklin, Henry F., Pan, Mei-Hsiu, Hanrahan, Stephen M., Feng, Jin Jin, He, Jiang, Sounni, Nor Eddine, Dill, Ken A., Contag, Christopher H., Coussens, Lisa M., Franc, Benjamin L.

    Published in Bioorganic & medicinal chemistry (15-01-2009)
    “…Design strategy combining computational chemistry, parallel synthesis and protease cleavage studies has yielded a promising MMP-14 sensitive probe for SPECT…”
    Get full text
    Journal Article Web Resource
  20. 20

    16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors by VanBrocklin, H F, Rocque, P A, Lee, H V, Carlson, K E, Katzenellenbogen, J A, Welch, M J

    Published in Life sciences (1973) (1993)
    “…16 beta-[18F]Fluoromoxestrol (beta FMOX, 1) is a highly selective, metabolically stable estrogen with potential as a receptor imaging agent. It demonstrates…”
    Get more information
    Journal Article